Official data showed that China saw robust growth in the outstanding sum of loans to micro, small and medium enterprises (MSMEs) by the end of 2024 amid government efforts to encourage inclusive ...
Following strong gains in Q3, the Russell 1000® Value Index finished slightly lower in Q4, declining -1.98%. For the year, ...
Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...
Cigna Healthcare has named longtime benefits industry veteran Paul Virtell as president of its Supplemental Health business, where he will be responsible for the overall strategy, daily operations, ...
CompanyOverview\|NYSE:HUM] Health insurance giant Humana Inc. (NYSE: HUM) stock initially rose in reaction to its fourth quarter of 2024 earnings report despite pos ...
Cigna's strong growth potential, Evernorth expansion, and stock buybacks make it undervalued. Click here to find out why CI ...
Health insurance company Cigna (NYSE:CI) announced better-than-expected revenue in Q4 CY2024, with sales up 28.4% year on year to $65.65 billion. The company expects the full year’s revenue to be ...
Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Cigna (CI) to $341 from $370 and keeps an Equal Weight rating on the ...
Aristotle Atlantic Core Equity Strategy highlighted stocks like The Cigna Group (NYSE:CI) in its Q4 2024 investor letter and explained its insights for the company. The Cigna Group (NYSE:CI) is a ...
Aristotle Atlantic Core Equity Strategy highlighted stocks like The Cigna Group (NYSE:CI) in its Q4 2024 investor letter and explained its insights for the company. The Cigna Group (NYSE ...
Cigna's actual EPS of $6.64 for Q4 fell short of the forecasted $7.79, representing a 14.7% miss. However, revenue of $65.65 billion surpassed expectations by 3.9%, indicating strong top-line ...